Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 25, 2009
Grant Date -
Jan 11, 2007
app pub date -
Apr 26, 2005
filing date -
Apr 26, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention discloses aptamers capable of binding to Immunoglobulin E (“IgE”) useful as therapeutics in and diagnostics of atopic disease and/or other diseases or disorders in which IgE has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to IgE.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully